LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

Search

NeoGenomics Inc

Closed

8.11 1.37

Overview

Share price change

24h

Current

Min

7.86

Max

8.44

Key metrics

By Trading Economics

Income

-19M

-45M

Sales

13M

181M

Profit margin

-24.867

Employees

2,200

EBITDA

-41M

-48M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+33.54% upside

Dividends

By Dow Jones

Next Earnings

4 lis 2025

Market Stats

By TradingEconomics

Market Cap

212M

1B

Previous open

6.74

Previous close

8.11

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

NeoGenomics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

17 wrz 2025, 21:59 UTC

Earnings

Cryptocurrency-Exchange Bullish Swings to Profit in First Report as Public Company

16 wrz 2025, 16:49 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

GD Culture Shares Drop After Deal for Pallas Capital

15 wrz 2025, 16:43 UTC

Major Market Movers

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 wrz 2025, 16:42 UTC

Major Market Movers

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

12 wrz 2025, 16:04 UTC

Major Market Movers

Upexi Shares Climb on Solana Gains

12 wrz 2025, 15:03 UTC

Major Market Movers

Allied Gaming & Entertainment Shares Surge Following Crypto Investments

11 wrz 2025, 18:04 UTC

Major Market Movers

Mogu Shares Hit 52-Week High After Board Approves Digital-Currency Fund

9 wrz 2025, 20:30 UTC

Earnings

GameStop 2Q Sales, Profit Rise

9 wrz 2025, 16:56 UTC

Major Market Movers

CaliberCos Shares Skyrocket on Chainlink Purchase

9 wrz 2025, 14:49 UTC

Major Market Movers

QMMM Shares Hit 52-Week High After Move Into Cryptocurrency, Blockchain Sector

8 wrz 2025, 17:01 UTC

Major Market Movers

Eightco Holdings Stock Surges as Dan Ives Joins Board Amid Crypto Push

8 wrz 2025, 17:01 UTC

Major Market Movers

Tron Shares Rise After New Investment From Bravemorning

8 wrz 2025, 15:14 UTC

Acquisitions, Mergers, Takeovers

CoinShares to Go Public by Merging With SPAC

17 wrz 2025, 07:35 UTC

Market Talk

Bitcoin Hits Nearly 4-Week High Ahead of Fed Decision -- Market Talk

16 wrz 2025, 14:33 UTC

Market Talk

Most Investors Have Zero Allocation to Crypto -- Market Talk

16 wrz 2025, 12:31 UTC

Acquisitions, Mergers, Takeovers

CleanCore Acquires Additional 100M DOGE, Expanding Digital Asset Treasury to Over 600M DOGE

16 wrz 2025, 07:54 UTC

Market Talk

Bitcoin Edges Higher After Wall Street Rally -- Market Talk

15 wrz 2025, 12:34 UTC

Acquisitions, Mergers, Takeovers

Nature's Miracle Plans to Acquire $20M Carbon Credit Portfolio to Develop XRP-Based Tokenized Carbon Product

15 wrz 2025, 10:28 UTC

Market Talk

Crypto Assets Could Benefit if Fed Signals More Rate Cuts -- Market Talk

15 wrz 2025, 07:13 UTC

Market Talk

Bitcoin Rises on Fed Rate Cut Bets -- Market Talk

12 wrz 2025, 07:09 UTC

Market Talk

Bitcoin Rises After Wall Street Indices Hit Fresh Records -- Market Talk

12 wrz 2025, 04:01 UTC

Acquisitions, Mergers, Takeovers

Bitcoin Is Hot, Gold Is Hotter. How These Worlds Collide. -- Barrons.com

11 wrz 2025, 07:31 UTC

Market Talk

Global Equities Roundup: Market Talk

11 wrz 2025, 07:31 UTC

Market Talk

Bitcoin Rises After S&P 500, Nasdaq Reach Record Highs -- Market Talk

10 wrz 2025, 20:08 UTC

Acquisitions, Mergers, Takeovers

Lixte Biotechnology: Purchased 10.5 Bitcoin and 300 Ethereum for Approximately $2.6M, Part of Strategy to Strengthen Treasury Position, Expand Ability to Transact Across Multiple Mediums >LIXT

10 wrz 2025, 07:44 UTC

Market Talk

Bitcoin Lifted Slightly by U.S. Rate Cut Bets -- Market Talk

9 wrz 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9 wrz 2025, 08:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 wrz 2025, 08:02 UTC

Market Talk

Bitcoin Rises as Rate Cut Bets Boost Risk Appetite -- Market Talk

8 wrz 2025, 16:16 UTC

Earnings

Strategy Stock May Not Ever Make It Into the S&P 500 Index -- Barrons.com

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

33.54% upside

12 Months Forecast

Average 10.67 USD  33.54%

High 14 USD

Low 8 USD

Based on 11 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

5

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat